Sep 082020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, VA –  Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), today announced the appointment of Dr. Bob Cobuzzi who has served as a member of the Board of Directors since January 2020, as President and CEO effective immediately, succeeding David Kalergis. Mr. Kalergis will retire from his operational responsibilities but continue ...

Diffusion Pharmaceuticals appoints Board member Dr. Bob Cobuzzi as CEO alongside David Kalergis remaining as Chairman

Diffusion Pharmaceuticals appoints Board member Dr. Bob Cobuzzi as CEO alongside David Kalergis remaining as Chairman

From:: Diffusion Pharmaceuticals appoints Board member Dr. Bob Cobuzzi as CEO alongside David Kalergis remaining as Chairman

Sorry, the comment form is closed at this time.